Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - 103 Studies Found
Active, not recruiting |
: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study :
: 2012-04-25 : Other: Observational Observational study of subjects previously enrolled in the RAVE trial |
Completed |
: Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis :
: 2006-02-16 : Drug: Rituximab |
Active, not recruiting |
: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis :
: 2014-06-19 :
|
Active, not recruiting |
: Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis : Vasculitis : 2005-08-09 : Drug: azathioprine azathioprine 2 mg/kg oral once daily, duration according to arm |
Completed |
: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides :
: 2015-06-10 : Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Recruiting |
: Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) :
: 2005-02-14 :
|
Recruiting |
: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) :
: |
Completed |
: Efficacy Study of Two Treatments in the Remission of Vasculitis :
: 2008-09-05 :
|
Completed |
: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis :
|